2022 Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications View PDF
2021 2021 Annual Meeting: Assessing the Use of ctDNA as an Early Endpoint in Early-Stage Disease View PDF
2021 Harmonizing the Definition and Reported of Cytokine Release Syndrome (CRS) in Immuno-Oncology Clinical Trials View PDF
2019 2019 Annual Meeting: Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products View PDF
2019 2019 Annual Meeting: Immuno-Oncology Combination Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy View PDF
